All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Corporate BondsHigh grade and crossover bonds

AstraZeneca heads to euros for more acquisition funding

Pharma_drugs_adobe_575x375.jpg

AstraZeneca, the UK drug maker, hit the euro market on Wednesday after printing $7bn across the Atlantic a day earlier. The borrower is building up funds to pay for its $39bn acquisition of US rival Alexion Pharmaceuticals.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree